Ageing cells rewire their nucleus to change behaviour
When cells age, more changes than their appearance. Deep inside the cell nucleus, a reorganisation takes place that determines which genes are switched on or off. New research reveals how this process works and how it can be slowed.
Senescent cells are cells that have stopped dividing but do not die. They accumulate in tissues and send inflammatory signals into their surroundings. This contributes to a range of age-related diseases. But exactly what happens inside the nucleus of such a cell was not well understood.
Researchers, publishing in Nature Aging, found that a protein called CTCF accumulates in specific nuclear structures called nuclear speckles when cells become senescent. Normally, CTCF helps organise DNA. In senescent cells, these proteins cluster in a different location, altering how genetic material is read. Specifically, this affects a process called alternative splicing: the way genes are converted into proteins. The result is a protein programme that looks very different from that of young cells.
Intervention is possible
The researchers tested whether this reorganisation could be counteracted. Interventions that disrupted the nuclear restructuring also delayed the onset of senescence. That is an interesting finding, though these are still laboratory experiments. Whether the approach works in living organisms and is safe remains to be investigated.
The study does provide a more concrete mechanistic picture of how senescent cells influence their environment. They not only change their behaviour but also the way they process genetic information. That makes the nucleus a potential new target in ageing research.
Broader implications for ageing research
Senescence is one of the most studied mechanisms in the biology of ageing. Earlier work focused mainly on the inflammatory proteins that senescent cells secrete. This study adds a layer: the altered gene regulation within the cell itself. Both processes are connected and can reinforce each other. That suggests future therapies may need to act on multiple levels simultaneously.
Want to research this yourself?
Search for example:
- cellular senescence chromatin reorganisation
- alternative splicing ageing
- CTCF nuclear speckles